Literature DB >> 25005620

Simultaneous study of matrix metalloproteinases, proinflammatory cytokines, and soluble cytokine receptors in the tears of noninfectious corneal ulcer patients.

Tohru Sakimoto1, Takako Ohnishi, Akiko Ishimori.   

Abstract

BACKGROUND: We investigated the presence of matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), proinflammatory cytokines, and soluble cytokine receptors in the tear fluid of patients with noninfectious corneal ulcers in the peripheral cornea.
METHODS: The subjects were 20 eyes of 17 patients with peripheral noninfectious corneal ulcers and 20 eyes of 20 volunteers. Tear samples were taken by the Schirmer test I method and the presence of MMPs (MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MMP-10, and MMP-13) and TIMPs (TIMP-1, TIMP-2, and TIMP-4) were investigated using an MMP antibody array system. The concentrations of proinflammatory cytokines {IL-1β, IL-6, and TNF-α (tumor necrosis factor-alpha)} and soluble cytokine receptors {soluble (s) IL-1R1, sIL-1R2, sIL-2Rα, sIL-4R, sIL-6R, sTNFR1, sTNFR2, s-vascular endothelial growth factor receptor (VEGFR) 1, sVEGFR2, sVEGFR3, and sgp130} were determined using the multiplex bead immunoassay system.
RESULTS: The concentrations of MMP-8 and MMP-9 were significantly up-regulated in the tear fluid of the ulcer patients, whereas TIMPs concentrations did not change. The concentrations of IL-1β, IL-6, sIL-1R2, sIL-6R, sTNFR1, and sTNFR2 were up-regulated in the ulcer patients, whereas sgp130 and sVEGFR1 concentrations significantly decreased.
CONCLUSIONS: The presence of some MMPs increased significantly in the patients with peripheral noninfectious corneal ulcers, whereas the presence of TIMPs remained unchanged. Although some proinflammatory cytokines were up-regulated, their antagonists, soluble cytokine receptors, were also up-regulated. It is thus possible that the up-regulation of MMPs disrupts the balance between the MMPs and TIMPs and that this balance may play a pivotal role in the pathophysiology of corneal ulceration.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25005620     DOI: 10.1007/s00417-014-2708-1

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  21 in total

Review 1.  MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology.

Authors:  Jeremy M Sivak; M Elizabeth Fini
Journal:  Prog Retin Eye Res       Date:  2002-01       Impact factor: 21.198

Review 2.  Management of corneal perforation.

Authors:  Vishal Jhanji; Alvin L Young; Jod S Mehta; Namrata Sharma; Tushar Agarwal; Rasik B Vajpayee
Journal:  Surv Ophthalmol       Date:  2011 Nov-Dec       Impact factor: 6.048

Review 3.  Matrix metalloproteinases: regulators of the tumor microenvironment.

Authors:  Kai Kessenbrock; Vicki Plaks; Zena Werb
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

Review 4.  Twenty-five-year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection.

Authors:  M R Dana; Y Qian; P Hamrah
Journal:  Cornea       Date:  2000-09       Impact factor: 2.651

5.  Immunohistochemical observation of amniotic membrane patching on a corneal alkali burn in vivo.

Authors:  Hiroshi Takahashi; Tsutomu Igarashi; Chiaki Fujimoto; Noriko Ozaki; Masamichi Ishizaki
Journal:  Jpn J Ophthalmol       Date:  2007-02-09       Impact factor: 2.447

6.  Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis.

Authors:  Henrik Toft-Hansen; Robert K Nuttall; Dylan R Edwards; Trevor Owens
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

7.  Autoimmunity to a cornea-associated stromal antigen in patients with Mooren's ulcer.

Authors:  J D Gottsch; S H Liu; J B Minkovitz; D F Goodman; M Srinivasan; W J Stark
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-07       Impact factor: 4.799

Review 8.  The soluble interleukin-2 receptor as a marker for human neoplasia and immune status.

Authors:  B Zerler
Journal:  Cancer Cells       Date:  1991-12

9.  IL-1 beta scavenging by the type II IL-1 decoy receptor in human neutrophils.

Authors:  Emer Bourke; Arianna Cassetti; Antonello Villa; Emma Fadlon; Francesco Colotta; Alberto Mantovani
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

10.  Antibody array-generated cytokine profiles of tears of patients with vernal keratoconjunctivitis or giant papillary conjunctivitis.

Authors:  Jun Shoji; Noriko Inada; Mitsuru Sawa
Journal:  Jpn J Ophthalmol       Date:  2006 May-Jun       Impact factor: 2.211

View more
  7 in total

1.  Time-dependent matrix metalloproteinases and tissue inhibitor of metalloproteinases expression change in fusarium solani keratitis.

Authors:  Qian Li; Xin-Rui Gao; Hong-Ping Cui; Li-Li Lang; Xiu-Wen Xie; Qun Chen
Journal:  Int J Ophthalmol       Date:  2016-04-18       Impact factor: 1.779

2.  Corneal Cross-Linking Has No Effect on Matrix Metalloproteinase 9 and 13 Levels During Fungal Keratitis on the Early Stage.

Authors:  Ayse Kalkanci; Kamil Bilgihan; Huseyin Baran Ozdemir; Atiye Seda Yar Saglam; Funda Karakurt; Merve Erdogan
Journal:  Mycopathologia       Date:  2017-10-17       Impact factor: 2.574

3.  Tear Matrix Metalloproteinases and Myeloperoxidase Levels in Patients With Boston Keratoprosthesis Type I.

Authors:  Marie-Claude Robert; Samer N Arafat; Sandra Spurr-Michaud; James Chodosh; Claes H Dohlman; Ilene K Gipson
Journal:  Cornea       Date:  2016-07       Impact factor: 2.651

4.  Desiccating Stress-Induced MMP Production and Activity Worsens Wound Healing in Alkali-Burned Corneas.

Authors:  Fang Bian; Flavia S A Pelegrino; Stephen C Pflugfelder; Eugene A Volpe; De-Quan Li; Cintia S de Paiva
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-07       Impact factor: 4.799

5.  Use of Plasma Rich in Growth Factors and ReGeneraTing Agent Matrix for the Treatment of Corneal Diseases.

Authors:  Ronald M Sánchez-Ávila; Edmar Uribe-Badillo; Carlos Fernández-Vega González; Francisco Muruzabal; Borja de la Sen-Corcuera; Begoña Baamonde; Luis M Quirós; Eduardo Anitua; Jesús Merayo-Lloves
Journal:  Vision (Basel)       Date:  2021-07-02

6.  The role of IL-6-174 G/C polymorphism and intraocular IL-6 levels in the pathogenesis of ocular diseases: a systematic review and meta-analysis.

Authors:  Zulvikar Syambani Ulhaq; Gita Vita Soraya; Lely Retno Wulandari
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

7.  In vitro validation of the tear matrix metalloproteinase 9 in-situ immunoassay.

Authors:  Seung Pil Bang; Myeong Jin Son; Harim Kim; You Hyun Lee; Jong Hwa Jun
Journal:  Sci Rep       Date:  2020-09-15       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.